產(chǎn)品名稱 Ambrisentan - BSF 208075 | Letairis | Volibris
產(chǎn)品貨號(hào) Axon 1648 CAS [177036-94-1] MF C22H22N2O4MW 378.42 Purity: 98% Optical purity: Optically pure Soluble in DMSO Description Orally active non-peptide endothelin-A (ETA) receptor antagonist; therapeutic agent for the treatment of pulmonary arterial hypertension References Certificates Categories Extra info H Vatter and V Seifert. Ambrisentan, a non-peptide endothelin receptor antagonist. Cardiovasc Drug Rev 2006,?24 (1), 63–76. ? CC Chong. Ambrisentan: A new, nonsulphonamide, selective endothelin receptor antagonist for the treatment of pulmonary arterial hypertension. PVRI Review 2009, 1, 31-33. ? H Riechers et al. Discovery and Optimization of a Novel Class of Orally Active Nonpeptidic Endothelin-A Receptor Antagonists. J. Med. Chem., 1996, 39(11), 2123–2128. Certificate of Analysis Material Safety Data Sheet CNS ETA Endocrinology A7 Endothelin-A (ETA) antagonist Chemical name (S)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid Parent CAS No. [177036-94-1] Order Size Unit Price Stock 5 mg €75.00 In Stock
產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià),電話:010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

Ambrisentan - BSF 208075 | Letairis | Volibris

Based on 15 reference(s) in Google Scholar 8 10 15

Axon 1648

CAS [177036-94-1]

MF C22H22N2O4
MW 378.42

  • Purity: 98%
  • Optical purity: Optically pure
  • Soluble in DMSO

Ambrisentan

Description

Orally active non-peptide endothelin-A (ETA) receptor antagonist; therapeutic agent for the treatment of pulmonary arterial hypertension
產(chǎn)品資料